ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Operational Highlights and Upcoming Milestones
|
|
TobiasInvest
|
177 |
57K |
15 |
31/03/21 |
31/03/21 |
ASX - By Stock
|
177
|
57K
|
15
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading 2021 - paradigm shift
|
|
TobiasInvest
|
10K |
3.0M |
0 |
26/03/21 |
26/03/21 |
ASX - By Stock
|
10K
|
3.0M
|
0
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading 2021 - paradigm shift
|
|
TobiasInvest
|
10K |
3.0M |
5 |
17/03/21 |
17/03/21 |
ASX - By Stock
|
10K
|
3.0M
|
5
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading 2021 - paradigm shift
|
|
TobiasInvest
|
10K |
3.0M |
5 |
17/03/21 |
17/03/21 |
ASX - By Stock
|
10K
|
3.0M
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
TobiasInvest
|
17K |
6.6M |
0 |
16/03/21 |
16/03/21 |
ASX - By Stock
|
17K
|
6.6M
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
TobiasInvest
|
17K |
6.6M |
12 |
16/03/21 |
16/03/21 |
ASX - By Stock
|
17K
|
6.6M
|
12
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading 2021 - paradigm shift
|
|
TobiasInvest
|
10K |
3.0M |
5 |
12/03/21 |
12/03/21 |
ASX - By Stock
|
10K
|
3.0M
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Raises US$110M Led By US Strategic Investor Group
|
|
TobiasInvest
|
508 |
170K |
4 |
02/03/21 |
02/03/21 |
ASX - By Stock
|
508
|
170K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Trading Halt
|
|
TobiasInvest
|
272 |
137K |
1 |
26/02/21 |
26/02/21 |
ASX - By Stock
|
272
|
137K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Remestemcel-L for COVID-19 MIS-C published in Pediatrics
|
|
TobiasInvest
|
423 |
124K |
1 |
21/02/21 |
21/02/21 |
ASX - By Stock
|
423
|
124K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Phase 3 Chronic Low Back Pain Results
|
|
TobiasInvest
|
1.1K |
310K |
0 |
13/02/21 |
13/02/21 |
ASX - By Stock
|
1.1K
|
310K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Phase 3 Chronic Low Back Pain Results
|
|
TobiasInvest
|
1.1K |
310K |
4 |
11/02/21 |
11/02/21 |
ASX - By Stock
|
1.1K
|
310K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Phase 3 Chronic Low Back Pain Results
|
|
TobiasInvest
|
1.1K |
310K |
7 |
11/02/21 |
11/02/21 |
ASX - By Stock
|
1.1K
|
310K
|
7
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Phase 3 Chronic Low Back Pain Results
|
|
TobiasInvest
|
1.1K |
310K |
6 |
11/02/21 |
11/02/21 |
ASX - By Stock
|
1.1K
|
310K
|
6
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Phase 3 Chronic Low Back Pain Results
|
|
TobiasInvest
|
1.1K |
310K |
6 |
11/02/21 |
11/02/21 |
ASX - By Stock
|
1.1K
|
310K
|
6
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Phase 3 Chronic Low Back Pain Results
|
|
TobiasInvest
|
1.1K |
310K |
29 |
11/02/21 |
11/02/21 |
ASX - By Stock
|
1.1K
|
310K
|
29
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading 2021 - paradigm shift
|
|
TobiasInvest
|
10K |
3.0M |
1 |
02/02/21 |
02/02/21 |
ASX - By Stock
|
10K
|
3.0M
|
1
|
|
ASX - By Stock
|
MSB |
Re:
MSB Short Position Reporting
|
|
TobiasInvest
|
255 |
83K |
6 |
31/01/21 |
31/01/21 |
ASX - By Stock
|
255
|
83K
|
6
|
|
ASX - By Stock
|
MSB |
Re:
Partnerships vs FDA
|
|
TobiasInvest
|
63 |
25K |
10 |
22/01/21 |
22/01/21 |
ASX - By Stock
|
63
|
25K
|
10
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading 2021 - paradigm shift
|
|
TobiasInvest
|
10K |
3.0M |
0 |
12/01/21 |
12/01/21 |
ASX - By Stock
|
10K
|
3.0M
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Rexlemestrocel Reduces Heart Attacks/Strokes/CV Death in CHF
|
|
TobiasInvest
|
763 |
323K |
4 |
11/01/21 |
11/01/21 |
ASX - By Stock
|
763
|
323K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Update on COVID-19 ARDS Trial
|
|
TobiasInvest
|
1.0K |
515K |
1 |
19/12/20 |
19/12/20 |
ASX - By Stock
|
1.0K
|
515K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Webcast
|
|
TobiasInvest
|
183 |
94K |
11 |
18/12/20 |
18/12/20 |
ASX - By Stock
|
183
|
94K
|
11
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Trading halt
|
|
TobiasInvest
|
796 |
393K |
0 |
16/12/20 |
16/12/20 |
ASX - By Stock
|
796
|
393K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
COVID-19 USA Daily Numbers
|
|
TobiasInvest
|
675 |
191K |
2 |
16/12/20 |
16/12/20 |
ASX - By Stock
|
675
|
191K
|
2
|
|
Charts
|
MSB |
Re:
MSB Charts
|
|
TobiasInvest
|
888 |
641K |
0 |
16/12/20 |
16/12/20 |
Charts
|
888
|
641K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Phase 3 Chronic Heart Failure Results
|
|
TobiasInvest
|
1.0K |
416K |
1 |
15/12/20 |
15/12/20 |
ASX - By Stock
|
1.0K
|
416K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Phase 3 Chronic Heart Failure Results
|
|
TobiasInvest
|
1.0K |
416K |
2 |
15/12/20 |
15/12/20 |
ASX - By Stock
|
1.0K
|
416K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Phase 3 Chronic Heart Failure Results
|
|
TobiasInvest
|
1.0K |
416K |
31 |
15/12/20 |
15/12/20 |
ASX - By Stock
|
1.0K
|
416K
|
31
|
|
ASX - By Stock
|
MSB |
Re:
Phase 3 DREAM HF-1 read-out
|
|
TobiasInvest
|
344 |
178K |
13 |
11/12/20 |
11/12/20 |
ASX - By Stock
|
344
|
178K
|
13
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading 2020 - a new dawn
|
|
TobiasInvest
|
13K |
4.9M |
4 |
11/12/20 |
11/12/20 |
ASX - By Stock
|
13K
|
4.9M
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Phase 3 DREAM HF-1 read-out
|
|
TobiasInvest
|
344 |
178K |
1 |
11/12/20 |
11/12/20 |
ASX - By Stock
|
344
|
178K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
TobiasInvest
|
17K |
6.6M |
2 |
10/12/20 |
10/12/20 |
ASX - By Stock
|
17K
|
6.6M
|
2
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading 2020 - a new dawn
|
|
TobiasInvest
|
13K |
4.9M |
16 |
10/12/20 |
10/12/20 |
ASX - By Stock
|
13K
|
4.9M
|
16
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading 2020 - a new dawn
|
|
TobiasInvest
|
13K |
4.9M |
2 |
09/12/20 |
09/12/20 |
ASX - By Stock
|
13K
|
4.9M
|
2
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading 2020 - a new dawn
|
|
TobiasInvest
|
13K |
4.9M |
1 |
09/12/20 |
09/12/20 |
ASX - By Stock
|
13K
|
4.9M
|
1
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading 2020 - a new dawn
|
|
TobiasInvest
|
13K |
4.9M |
6 |
09/12/20 |
09/12/20 |
ASX - By Stock
|
13K
|
4.9M
|
6
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading 2020 - a new dawn
|
|
TobiasInvest
|
13K |
4.9M |
2 |
09/12/20 |
09/12/20 |
ASX - By Stock
|
13K
|
4.9M
|
2
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading 2020 - a new dawn
|
|
TobiasInvest
|
13K |
4.9M |
1 |
09/12/20 |
09/12/20 |
ASX - By Stock
|
13K
|
4.9M
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Remestemcel-L FDA Fast Track Designation for COVID-19 ARDS
|
|
TobiasInvest
|
572 |
250K |
12 |
08/12/20 |
08/12/20 |
ASX - By Stock
|
572
|
250K
|
12
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading 2020 - a new dawn
|
|
TobiasInvest
|
13K |
4.9M |
6 |
08/12/20 |
08/12/20 |
ASX - By Stock
|
13K
|
4.9M
|
6
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading 2020 - a new dawn
|
|
TobiasInvest
|
13K |
4.9M |
8 |
08/12/20 |
08/12/20 |
ASX - By Stock
|
13K
|
4.9M
|
8
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Remestemcel-L Reduces Biomarkers for Mortality in SR-aGVHD
|
|
TobiasInvest
|
139 |
72K |
1 |
08/12/20 |
08/12/20 |
ASX - By Stock
|
139
|
72K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading 2020 - a new dawn
|
|
TobiasInvest
|
13K |
4.9M |
0 |
08/12/20 |
08/12/20 |
ASX - By Stock
|
13K
|
4.9M
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Remestemcel-L Reduces Biomarkers for Mortality in SR-aGVHD
|
|
TobiasInvest
|
139 |
72K |
6 |
08/12/20 |
08/12/20 |
ASX - By Stock
|
139
|
72K
|
6
|
|
ASX - By Stock
|
MSB |
Re:
Guess the opening price - if ARDS halted due supreme efficacy
|
|
TobiasInvest
|
416 |
130K |
1 |
08/12/20 |
08/12/20 |
ASX - By Stock
|
416
|
130K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading 2020 - a new dawn
|
|
TobiasInvest
|
13K |
4.9M |
3 |
07/12/20 |
07/12/20 |
ASX - By Stock
|
13K
|
4.9M
|
3
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading 2020 - a new dawn
|
|
TobiasInvest
|
13K |
4.9M |
4 |
07/12/20 |
07/12/20 |
ASX - By Stock
|
13K
|
4.9M
|
4
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading 2020 - a new dawn
|
|
TobiasInvest
|
13K |
4.9M |
4 |
07/12/20 |
07/12/20 |
ASX - By Stock
|
13K
|
4.9M
|
4
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading 2020 - a new dawn
|
|
TobiasInvest
|
13K |
4.9M |
2 |
06/12/20 |
06/12/20 |
ASX - By Stock
|
13K
|
4.9M
|
2
|
|